TransMedics (TMDX 1.67%) has been hit hard as investors question margins, spending, and execution. But beneath the sell-off, the company's Organ Care System, aviation network, and National OCS Program could be building a deeper transplant infrastructure moat than the market realizes.
*Stock prices used were the market prices of May 25, 2026. The video was published on June 1, 2026.




